Stockreport

Nymox up 3% on article supporting efficacy of lead drug [Seeking Alpha]

Nymox Pharmaceutical Corporation  (NYMX) 
US:NASDAQ Investor Relations: nymox.com/default.action?itemid=3
PDF Nymox up 3% on article supporting efficacy of lead drugThinly traded micro cap Nymox Pharmaceutical (NYMX+3.3%) is up on average volume in apparent response to anarticle [Read more]